Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine

  title={Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine},
  author={Stephen D. Silberstein and Lulu Lee and Kavita Gandhi and Timothy P. Fitzgerald and Jvawnna D Bell and Joshua M. Cohen},
  journal={Headache: The Journal of Head and Face Pain},
To examine the disability, health care resource utilization, and direct annual costs among patients with migraine, categorized according to the number of headache days experienced in the past month. 

Healthcare utilization and costs among patients with chronic migraine, episodic migraine, and tension‐type headache enrolled in commercial insurance plans

To quantify and compare healthcare utilization and costs for patients with chronic migraine, episodic migraine (EM), and tension‐type headache (TTH) enrolled in US commercial health plans, a large number of patients are enrolled in commercial plans.

Episodic and Chronic Migraine in Primary Care

To inform migraine care model development by assessing differences between patients with chronic migraine (CM) and episodic migraine (EM) in the current state of treatment, disability, patient

Impact of emergency department opioid use on future health resource utilization among patients with migraine

The purpose of this study was to evaluate the subsequent health resource utilization (HRU) between patients with migraine who received opioid medications at their emergency department (ED) visits

Demographics, Headache Features, and Comorbidity Profiles in Relation to Headache Frequency in People With Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study

Characterizing more narrow headache day frequency groups may be of value for better understanding the broad range of migraine experience and making treatment decisions.

Estimating the savings associated with a migraine‐free life: results from the Spanish Atlas

The aims of this study were to quantify the costs of chronic and episodic migraine in Spain, evaluating the impact of psychiatric comorbidities and disability, and to estimate the economic savings associated with reducing the number of migraine‐days by 50%.

Management of Childhood Migraine by Headache Specialist vs Non‐Headache Specialists

The use of appropriate rescue medications and prophylactic agents, application of neuroimaging, and short‐term outcomes are compared in children treated by the two groups of physicians.

Behavioral Therapy Preferences in People With Migraine

There are safe and well‐tolerated level A evidence‐based behavioral therapies for the prevention of migraine. They are biofeedback, cognitive behavioral therapy, and relaxation. However, the

Migraine: Epidemiology, Burden, and Comorbidity.

Systematic review of outcomes and endpoints in preventive migraine clinical trials

Over the last six decades, clinical trials of migraine preventive treatments have led to the regulatory approval of many medications and devices, but the outcomes and endpoints used in these trials are broad and not well standardized.

Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care

Migraine burden increased by each failed treatment line and was associated with increasedComorbidity, and migraine patients had significantly higher extent of visits and sick-leave days as well as extent of comorbidities when compared to their age- and gender-matched counterparts.



Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study

Background.— Though symptomatic medication overuse is believed to play a major role in progression from episodic to chronic or transformed migraine (TM), population‐based longitudinal data on these

Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS‐II)

The objective was to characterize patterns of preventive medication use in persons with episodic migraine (EM) and chronic migraine (CM) and to establish a baseline level of trust in the use of these medications.

Similarities and Differences Between Chronic Migraine and Episodic Migraine

Objective.—To quantify and characterize the similarities and the differences between chronic migraine (CM) patients with medication overuse and episodic migraine (EM) patients with only occasional

Frequency and Burden of Headache‐Related Nausea: Results From the American Migraine Prevalence and Prevention (AMPP) Study

While nausea is a defining feature of migraine, the association of nausea with other headache features and its influence on the burden of migraine have not been quantified. Population‐based data were

Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study

Direct costs of migraine increase with increasing frequency of migraine-associated nausea, and both frequency and severity of headache-related nausea should be monitored as part of ongoing care of persons with migraine.

Persistent Frequent Nausea Is Associated With Progression to Chronic Migraine: AMPP Study Results

Persistent frequent headache‐related nausea (PFN) in persons with episodic migraine (EM) as a predictor of new onset chronic migraine (CM) is evaluated.

Considerations for management of migraine symptoms in the primary care setting

An overview of the prevalence, symptoms, burden, and diagnosis of migraine with a focus on adults is provided and insight is provided into factors for consideration when prescribing acute/abortive treatment for migraine to ensure that individual patients receive optimal pharmaceutical management.

Prophylaxis of migraine

The issues that guide the decision-making process in migraine preventive treatment are discussed, including the specific prophylactic approach needs to be individualized taking into account multiple variables.

The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis.

This study reviews the current understanding of the burden of migraine in the U.S., the history of economic understanding of migraine treatment and identifies emergent trends for future studies evaluating clinical and economic outcomes of migraines.